CGT Oncology Trials: IRB/IBC Strategies, Trends and Operational Insights, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insight into proven IRB/IBC strategies that streamline regulatory compliance and keep cell and gene therapy (CGT) oncology trials moving forward without costly delays. The featured speakers will unlock insights into emerging operational trends shaping today's CGT landscape, from risk management to site readiness and patient-centered protocols. Attendees will take away real-world examples of operational wins that accelerate study start-up, safeguard patient safety and set trials up for long-term success.

TORONTO, Sept. 8, 2025 /PRNewswire/ -- Oncology cell and gene therapy (CGT) trials face persistent regulatory and operational challenges that can delay progress and impact outcomes. This session will move beyond high-level overviews to focus on common pain points, delivering actionable suggestions and information on successful tactics to best position trials from the regulatory, strategic and operational perspectives. Recognizing that most trials often get bogged down by red tape, regulatory confusion and operational bottlenecks, this webinar will focus on strategies to sidestep these challenges through IRB, IBC and operational approaches that not only meet regulatory requirements but also accelerate trials forward more efficiently and effectively.

The featured speakers will explore emerging trends disrupting the CGT oncology landscape — from adaptive trial designs and patient-centric approaches to next-level site readiness and capacity building. Attendees will understand how these trends translate into real operational wins that reduce startup delays, improve compliance and safeguard patient outcomes.

This session will also highlight how to coordinate IRB and IBC regulatory submissions into strategic advantages. Regulatory bodies and oversight committees aren't obstacles — they're partners, once their mechanics and processes are understood. This webinar will feature practical examples illustrating how top-performing teams leverage IRB/IBC relationships to expedite approvals without sacrificing integrity or safety.

By the end, attendees will hold a tactical playbook for elevating CGT oncology trials, one that goes beyond theory and delivers actionable strategies that could be the difference between a stalled trial and a success story. For professionals aiming to lead, innovate and advance CGT oncology, this webinar is essential.

Register for this webinar to learn how to drive efficiency and compliance in CGT oncology trials through integrated regulatory and operational strategies.

Join Patrick Melvin, Vice President, Therapeutic Strategy & Innovation, Syneos Health; Garry Coulson, Sr. Director, Regulatory & Quality, Sabai Global; and Michael Keens, CEO, Sabai Global, for the live webinar on Wednesday, September 24, 2025, at 11am EDT (4pm GMT/UK).

For more information or to register for this event, visit CGT Oncology Trials: IRB/IBC Strategies, Trends and Operational Insights.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit www.xtalks.com
For information about hosting a webinar, visit www.xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks